Invited Editorial on “the timing of surgery after neoadjuvant chemoradiation in locally advanced non-small cell lung cancer”
Articles > Article · 2017
Authors: Deniz YALMAN
Journal of Thoracic Disease, Journal Indexed in SCI Expanded, International, WoS, 2017, vol 9, pp E299-E300
Summary
Although the current standard of care in patients with locally advanced non-small cell lung cancer (NSCLC) is concurrent chemoradiotherapy, neoadjuvant chemoradiotherapy (NCRT) followed by surgery is increasingly used for selected Stage IIIA patients with potentially resectable tumors and limited N2 involvement.